Sujal M. Patel

CIK: 0001378830

Transaction Breakdown

Open Market Buys (P)5 (71.4%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NAUT

Nautilus Biotechnology, Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

NAUT
Nautilus Biotechnology, Inc.
Mar 4, 2026
Purchase(P)
Direct
25K shares at avg. $2.61$65K
NAUT
Nautilus Biotechnology, Inc.
Mar 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
650K shares-
NAUT
Nautilus Biotechnology, Inc.
Sep 8, 2025
Purchase(P)
Direct
83.5K shares at avg. $0.68$57K
NAUT
Nautilus Biotechnology, Inc.
Sep 5, 2025
Purchase(P)
Direct
116.5K shares at avg. $0.67$79K
NAUT
Nautilus Biotechnology, Inc.
Mar 20, 2025
Purchase(P)
Direct
23.9K shares at avg. $1.00$24K
NAUT
Nautilus Biotechnology, Inc.
Mar 19, 2025
Purchase(P)
Direct
53.3K shares at avg. $0.99$53K
NAUT
Nautilus Biotechnology, Inc.
Mar 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
650K shares-

		Type	Shares	Price		Ownership
Mar 4, 2026	NAUT Nautilus Biotechnology, Inc.	Purchase(P)	25,000	$2.61	$65,238	Direct
Mar 2, 2026	NAUT Nautilus Biotechnology, Inc.	Award(A) Stock Option (Right to Buy)	650,000	-	-	Direct
Sep 8, 2025	NAUT Nautilus Biotechnology, Inc.	Purchase(P)	83,500	$0.68	$57,031	Direct
Sep 5, 2025	NAUT Nautilus Biotechnology, Inc.	Purchase(P)	116,500	$0.67	$78,544	Direct
Mar 20, 2025	NAUT Nautilus Biotechnology, Inc.	Purchase(P)	23,933	$1.00	$23,890	Direct
Mar 19, 2025	NAUT Nautilus Biotechnology, Inc.	Purchase(P)	53,300	$0.99	$53,028	Direct
Mar 3, 2025	NAUT Nautilus Biotechnology, Inc.	Award(A) Stock Option (Right to Buy)	650,000	-	-	Direct

1-7 of 7 transactions

About Patel Sujal M

Patel Sujal M (SEC CIK 0001378830) files insider reports with the SEC as CEO, President, and Secretary of Nautilus Biotechnology, Inc. (NAUT).

Signal8 holds 5 ownership filings by Patel Sujal M, all Form 4s, filed between Mar 4, 2025 and Mar 4, 2026. Those filings report 7 transactions, from Mar 3, 2025 to Mar 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Patel Sujal M's filings is in SEATTLE, WA.

Recent filings by Patel Sujal M

Mar 4, 2026: Open-market purchase of NAUT shares (Form 4, code P).
Mar 2, 2026: Grant or award of NAUT derivative securities (Form 4, code A).
Sep 8, 2025: Open-market purchase of NAUT shares (Form 4, code P).
Sep 5, 2025: Open-market purchase of NAUT shares (Form 4, code P).
Mar 20, 2025: Open-market purchase of NAUT shares (Form 4, code P).

Other insiders filing for Nautilus Biotechnology, Inc. (NAUT)

Posard Matthew L., Director
NAZEM FARZAD, Director
Akinsanya Karen, Director
McIlwain Matthew S, Director
Epperly Melissa B,, Director
AH Equity Partners Bio II, L.L.C., 10% Owner

How to read Form 4 transaction codes